+ More
Technology
 News Room
Collaborations
 Contact Us

November is National Diabetes Month

Let's Think Long-Term about Diabetes Care

GlySens® is developing the Next Generation of Continuous Glucose Monitoring. The Eclipse® ICGM® system, a fully implanted (nothing worn on the skin), completely wireless and long-term (expected 1-year sensor life) CGM, for individuals living with and managing diabetes. The ICGM system is designed to provide continuous, at-a-glance glucose measurements, display trends, and provide alerts regarding hypo- and hyperglycemic glucose excursions. This is intended to empower individuals by providing the information they need, while freeing them to live life on their own terms.
Learn More

Our Commitment

The incidence of Diabetes is growing at a staggering pace so we are working hard for a healthier world.
Approximately 29.1 million Americans (9.3% of the population) have diabetes (both types) and as many as 2.5 million currently live with type 1, insulin-dependent diabetes (1).
Diabetes currently affects more than 415 million people globally and expected to exceed 642 million by 2040 (2).
Diagnosed diabetes results in a total cost of $245 billion to the U.S. economy, growing 8% each year and driven by complications of poor glucose control (3).
26% of the U.S. population aged 65 or older have diabetes. Nearly 1 in every 400 children in the U.S. has diabetes. (1).
Diabetes is a major cause of heart disease, stroke, kidney disease, blindness, and numerous other debilitating diseases and afflictions. It is the seventh leading cause of death in the U.S. (1).

Meet the Leadership

Development Status

Caution - INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL LAW TO INVESTIGATIONAL USE.
The Eclipse ICGM system is currently under development and is not yet approved, cleared, or otherwise available for commercial or public distribution. The system is currently undergoing clinical evaluation; initial human implant trials have been completed and preparations for additional human trials are underway.
Citations

1. Centers for Disease Control and Prevention. “National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014.” Atlanta, GA: U.S. Department of Health and Human Services; 2014.
2. International Diabetes Federation.  “IDF Diabetes Atlas Seventh Edition“.
3. American Diabetes Association. “Economic costs of Diabetes in the U.S. in 2012,” published 3/6/2013.
3931 Sorrento Valley Blvd
Suite 110
San Diego, CA 92121
Ph:  +1 (858) 638-7708
Fax: +1 (858) 638-7727

TechnologyNews RoomCareersContact Us

© 2017 GlySens Incorporated. All Rights Reserved.
Caution - INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL LAW TO INVESTIGATIONAL USE.
GlySens®, Eclipse®, and ICGM® are trademarks of GlySens Incorporated registered in the U.S. Patent and Trademark Office.
 Terms of Use Privacy Policy
map-markercogsphoneglobemoneylinkedinslidesharenewspaper-ousersheart-pulsepie-chartmenu